<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">V.F.Snegirev Archives of Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">V.F.Snegirev Archives of Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Архив акушерства и гинекологии им. В.Ф. Снегирева</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-8726</issn><issn publication-format="electronic">2687-1386</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">630395</article-id><article-id pub-id-type="doi">10.17816/aog630395</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original study articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="zh"><subject>Original study articles</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Correlation between inflammatory biomarkers in biological fluids in patients with ovarian endometriosis</article-title><trans-title-group xml:lang="ru"><trans-title>Соотношение воспалительных маркеров в биологических жидкостях у пациенток с эндометриоидными гетеротопиями яичников</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>卵巢子宫内膜异位性病灶患者生物液体中炎症标志物的相关性</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3413-1685</contrib-id><contrib-id contrib-id-type="spin">2388-0552</contrib-id><name-alternatives><name xml:lang="en"><surname>Mangileva</surname><given-names>Yana A.</given-names></name><name xml:lang="ru"><surname>Мангилева</surname><given-names>Яна Андреевна</given-names></name><name xml:lang="zh"><surname>Mangileva</surname><given-names>Yana A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Graduate Student</p></bio><bio xml:lang="ru"><p>аспирант</p></bio><bio xml:lang="zh"><p>Graduate Student</p></bio><email>yanaamangileva@mai.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2797-1926</contrib-id><contrib-id contrib-id-type="spin">7232-3743</contrib-id><name-alternatives><name xml:lang="en"><surname>Kudryavtseva</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Кудрявцева</surname><given-names>Елена Владимировна</given-names></name><name xml:lang="zh"><surname>Kudryavtseva</surname><given-names>Elena V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Assistant Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, доцент</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Medicine), Assistant Professor</p></bio><email>elenavladpopova@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4921-7222</contrib-id><contrib-id contrib-id-type="spin">4391-5873</contrib-id><name-alternatives><name xml:lang="en"><surname>Polushina</surname><given-names>Larisa G.</given-names></name><name xml:lang="ru"><surname>Полушина</surname><given-names>Лариса Георгиевна</given-names></name><name xml:lang="zh"><surname>Polushina</surname><given-names>Larisa G.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine), Senior Research Associate</p></bio><bio xml:lang="ru"><p>канд. мед. наук, старший научный сотрудник</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Medicine), Senior Research Associate</p></bio><email>polushina-larisa@bk.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-7306-4632</contrib-id><name-alternatives><name xml:lang="en"><surname>Shakiryanova</surname><given-names>Elvira I.</given-names></name><name xml:lang="ru"><surname>Шакирьянова</surname><given-names>Эльвира Ильсеновна</given-names></name><name xml:lang="zh"><surname>Shakiryanova</surname><given-names>Elvira I.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Head of the Department of Planned Gynecology</p></bio><bio xml:lang="ru"><p>зав. отделением плановой гинекологии</p></bio><bio xml:lang="zh"><p>Head of the Department of Planned Gynecology</p></bio><email>elechka175@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0761-2785</contrib-id><contrib-id contrib-id-type="spin">5065-9485</contrib-id><name-alternatives><name xml:lang="en"><surname>Potapov</surname><given-names>Nikolay N.</given-names></name><name xml:lang="ru"><surname>Потапов</surname><given-names>Николай Николаевич</given-names></name><name xml:lang="zh"><surname>Potapov</surname><given-names>Nikolay N.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Medicine)</p></bio><email>Poniknik@gmail.com</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8640-8418</contrib-id><contrib-id contrib-id-type="spin">2061-0704</contrib-id><name-alternatives><name xml:lang="en"><surname>Kovalev</surname><given-names>Vladislav V.</given-names></name><name xml:lang="ru"><surname>Ковалев</surname><given-names>Владислав Викторович</given-names></name><name xml:lang="zh"><surname>Kovalev</surname><given-names>Vladislav V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><email>vvkovalev55@gmail.com</email><xref ref-type="aff" rid="aff5"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Medical Center « UMMC-Health»</institution></aff><aff><institution xml:lang="ru">ООО «УГМК-Здоровье»</institution></aff><aff><institution xml:lang="zh">Medical Center « UMMC-Health»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Ural State Medical University</institution></aff><aff><institution xml:lang="ru">Уральский государственный медицинский университет</institution></aff><aff><institution xml:lang="zh">Ural State Medical University</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">City Clinical Hospital No. 14</institution></aff><aff><institution xml:lang="ru">Городская клиническая больница № 14</institution></aff><aff><institution xml:lang="zh">City Clinical Hospital No. 14</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">City Clinical Hospital No. 40</institution></aff><aff><institution xml:lang="ru">Городская клиническая больница № 40</institution></aff><aff><institution xml:lang="zh">City Clinical Hospital No. 40</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">Ural Institute of Health Management n.a. A.B. Blokhin</institution></aff><aff><institution xml:lang="ru">Уральский институт управления здравоохранением им. А.Б. Блохина</institution></aff><aff><institution xml:lang="zh">Ural Institute of Health Management n.a. A.B. Blokhin</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2024-12-12" publication-format="electronic"><day>12</day><month>12</month><year>2024</year></pub-date><pub-date date-type="pub" iso-8601-date="2024-12-22" publication-format="electronic"><day>22</day><month>12</month><year>2024</year></pub-date><volume>11</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>460</fpage><lpage>469</lpage><history><date date-type="received" iso-8601-date="2024-04-16"><day>16</day><month>04</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-09-29"><day>29</day><month>09</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2024,</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2026-12-22"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref></license></permissions><self-uri xlink:href="https://archivog.com/2313-8726/article/view/630395">https://archivog.com/2313-8726/article/view/630395</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND<italic>:</italic></bold><bold><italic> </italic></bold>To date, there are no available screening techniques allowing to distinguish groups of women with the risk of endometriosis. Therefore, many researchers are searching for meaningful biomarkers for non-invasive diagnosis. The peritoneal fluid is subject to multidirectional changes in patients with external genital endometriosis, although its sampling requires invasive procedure. Testing of the inflammatory markers in saliva is a simple and safe method of particular interest, given that its sampling is non-invasive.</p> <p><bold>AIM<italic>:</italic></bold><bold><italic> </italic></bold>To assess the correlations between the level of inflammatory biomarkers in the peritoneal fluid and saliva in patients with ovarian endometriosis.</p> <p><bold>MATERIAL AND METHODS<italic>:</italic></bold><bold><italic> </italic></bold>A prospective cohort comparative study of 46 women with ovarian endometriosis was carried out. Inclusion criteria: confirmed diagnosis of ovarian endometriosis; age between 18 and 40 years; written informed consent for surgical intervention and for participation in the study; no prior hormonal treatment. Non-inclusion criteria: patient's refusal to participate in the study; age below 18 and above 40 years; contraindications for surgical treatment; oral inflammatory diseases. Patients were excluded if the diagnosis could not be visually confirmed during surgery or if there were histological discrepancies. All patients underwent laparoscopic cystectomy. Peritoneal fluid samples were collected during surgery. Mixed unstimulated saliva was collected before surgery in the morning, on an empty stomach. The levels of interleukins and of vascular endothelial growth factor were assessed in biological fluids.</p> <p><bold>RESULTS<italic>:</italic></bold><bold><italic> </italic></bold>The mean age of the study subjects was 32,4±6,1 years. Correlation analysis showed a direct statistically significant moderate relationship between the levels of IL-6 (<italic>r</italic>=0.548; <italic>p</italic>=0.001) and IL-8 (<italic>r</italic>=0.360; <italic>p</italic>=0.026) in the peritoneal fluid and saliva, respectively.</p> <p><bold>CONCLUSION<italic>:</italic></bold><bold><italic> </italic></bold>These data suggest that the onset and progression of endometriosis are associated with the increase of inflammatory cytokine levels both in the peritoneal fluid and in saliva. This may serve a potential tool for diagnosis and assessment of the severity of endometriosis. Evaluation of IL-6 and IL-8 levels in saliva may be useful in clinical practice in patients with external genital endometriosis.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold><bold> </bold>На сегодняшний день не существует доступных скрининговых методик, позволяющих выделить группы риска женщин по эндометриозу, поэтому многие исследователи ведут поиск высокоинформативных маркеров для неинвазивной диагностики. Перитонеальная жидкость подвержена разнонаправленным изменениям при наружном генитальном эндометриозе, но её получение является инвазивной процедурой. Особый интерес представляет исследование слюны на содержание воспалительных маркеров, поскольку её получение является неинвазивной процедурой, относится к простым и безопасным методам.</p> <p><bold>Цель.</bold><bold> </bold>Оценить наличие корреляционных зависимостей между концентрацией воспалительных маркеров в перитонеальной жидкости и слюне при эндометриоидном поражении яичников.</p> <p><bold>Материал</bold><bold> </bold><bold>и</bold><bold> </bold><bold>методы</bold><bold>.</bold><bold> </bold>Проведено проспективное когортное сравнительное исследование 46 женщин с эндометриоидными кистами яичников. Критерии включения: подтверждённый диагноз «эндометриоз яичников»; репродуктивный возраст (18–40 лет); согласие пациентки на оперативное вмешательство и на участие в исследовании; отсутствие гормонального лечения до операции. Критерии невключения: отказ пациентки от участия в исследовании; возраст младше 18 и старше 40 лет; противопоказания к оперативному лечению; воспалительные заболевания ротовой полости. Критерии исключения: отсутствие визуального подтверждения диагноза при оперативном вмешательстве и по результатам гистологического исследования. Всем пациенткам была проведена лапароскопическая кистэктомия. Образцы перитонеальной жидкости были собраны во время оперативного вмешательства. Смешанную нестимулированную слюну собирали накануне операции утром, натощак. В биологических жидкостях оценивали уровень интерлейкинов и васкулоэндотелиального фактора роста.</p> <p><bold>Результаты.</bold><bold> </bold>Средний возраст пациенток, участвовавших в исследовании, составил 32,4±6,1 года. Корреляционный анализ показал прямую статистически значимую связь (средней силы) между концентрациями в перитонеальной жидкости и слюне IL-6 (<italic>r</italic>=0,548; <italic>p</italic>=0,001) и IL-8 (<italic>r</italic>=0,360; <italic>p</italic>=0,026).</p> <p><bold>Заключение.</bold><bold> </bold>Полученные результаты позволяют предположить, что при возникновении и прогрессировании эндометриоза не только в перитонеальной жидкости, но и в слюне увеличивается концентрация воспалительных цитокинов, которые могут быть потенциальным инструментом для диагностики и оценки степени тяжести эндометриоза. Оценка IL-6 и IL-8 в слюне может быть полезной в клинической практике при наличии у пациентки наружного генитального эндометриоза.</p></trans-abstract><trans-abstract xml:lang="zh"><p><bold>背景</bold>。目前尚无有效的筛查方法能够识别女性子宫内膜异位症的高风险群体，因此许多研究者正在探索非侵入性诊断的高信息量标志物。虽然腹膜液在外生殖器子宫内膜异位症中发生多方向变化，但其采集需通过侵入性操作。相比之下，唾液炎症标志物的研究因其采集方式非侵入、简单且安全，具有特别的研究价值。</p> <p><bold>研究目的</bold>。评估卵巢子宫内膜异位病变患者腹膜液与唾液中炎症标志物浓度之间的相关性。</p> <p><bold>材料与方法</bold>。对46名卵巢子宫内膜囊肿患者进行了前瞻性队列比较研究。纳入标准包括：确诊卵巢子宫内膜异位症；生育年龄（18~40岁）；患者同意手术和参与研究；术前未接受激素治疗。排除标准包括：患者拒绝参与研究；年龄小于18岁或大于40岁；存在手术禁忌症；口腔炎症性疾病。排除病例为：手术和组织学检查未能确认诊断的患者。所有患者均接受腹腔镜囊肿切除术，并在手术中采集腹膜液样本。术前清晨空腹采集混合的非刺激性唾液样本。对生物液体中的白细胞介素（Interleukin，IL）和血管内皮生长因子（Vascular Endothelial Growth Factor，VEGF）水平进行了评估。</p> <p><bold>结果</bold>。参与研究患者的平均年龄为32.4±6.1岁。相关性分析显示，腹膜液与唾液中IL-6（r=0.548；p=0.001）和IL-8（r=0.360；p=0.026）浓度之间存在中等强度的正相关性，且具有统计学显著性。</p> <p><bold>结论</bold>。研究结果表明，在子宫内膜异位症的发生和进展过程中，不仅腹膜液中炎症细胞因子的浓度增加，唾液中的浓度也随之升高。这些炎症细胞因子可能成为诊断和评估子宫内膜异位症严重程度的潜在工具。唾液中IL-6和IL-8的检测在外生殖器子宫内膜异位症患者的临床实践中具有重要意义。</p></trans-abstract><kwd-group xml:lang="en"><kwd>endometriosis</kwd><kwd>endometrioma</kwd><kwd>interleukins</kwd><kwd>saliva</kwd><kwd>biomarker</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>эндометриоз</kwd><kwd>эндометриома</kwd><kwd>интерлейкины</kwd><kwd>слюна</kwd><kwd>биомаркер</kwd></kwd-group><kwd-group xml:lang="zh"><kwd>子宫内膜异位症</kwd><kwd>内膜囊肿</kwd><kwd>白细胞介素</kwd><kwd>唾液</kwd><kwd>生物标志物</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. doi: 10.1093/hropen/hoac009</mixed-citation><mixed-citation xml:lang="ru">Becker C.M., Bokor A., Heikinheimo O., et al. ESHRE guideline: endometriosis // Hum Reprod Open. 2022. Vol. 2022, N 2. P. hoac009. doi: 10.1093/hropen/hoac009</mixed-citation><mixed-citation xml:lang="zh">Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. doi: 10.1093/hropen/hoac009</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Adamyan LV, Andreeva EN. Endometriosis and its global impact on a woman’s body. Russian Journal of Human Reproduction. 2022;28(1):54–64. EDN: ELOTDZ doi: 10.17116/repro20222801154</mixed-citation><mixed-citation xml:lang="ru">Адамян Л.В., Андреева Е.Н. Эндометриоз и его глобальное влияние на организм женщины // Проблемы репродукции. 2022. Т. 28, № 1. С. 54–64. EDN: ELOTDZ doi: 10.17116/repro20222801154</mixed-citation><mixed-citation xml:lang="zh">Adamyan LV, Andreeva EN. Endometriosis and its global impact on a woman’s body. Russian Journal of Human Reproduction. 2022;28(1):54–64. EDN: ELOTDZ doi: 10.17116/repro20222801154</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–1256. doi: 10.1056/NEJMra1810764</mixed-citation><mixed-citation xml:lang="ru">Zondervan K.T, Becker C.M, Missmer S.A. Endometriosis // N Engl J Med. 2020. Vol. 382, N 13. P. 1244–1256. doi: 10.1056/NEJMra1810764</mixed-citation><mixed-citation xml:lang="zh">Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–1256. doi: 10.1056/NEJMra1810764</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Sukhikh GT, Serov VN, Adamyan LV, et al. Algorithms for the management of patients with endometriosis: an agreed position of experts from the Russian Society of Obstetricians and Gynecologists. Akusherstvo i Ginekologiya. 2023;(5):159–176. EDN: DTJOZV doi: 10.18565/aig.2023.132</mixed-citation><mixed-citation xml:lang="ru">Сухих Г.Т, Серов В.Н., Адамян Л.В., и др. Алгоритмы ведения пациенток с эндометриозом: согласованная позиция экспертов Российского общества акушеров-гинекологов // Акушерство и гинекология. 2023. № 5. С. 159–76. EDN: DTJOZV doi: 10.18565/aig.2023.132</mixed-citation><mixed-citation xml:lang="zh">Sukhikh GT, Serov VN, Adamyan LV, et al. Algorithms for the management of patients with endometriosis: an agreed position of experts from the Russian Society of Obstetricians and Gynecologists. Akusherstvo i Ginekologiya. 2023;(5):159–176. EDN: DTJOZV doi: 10.18565/aig.2023.132</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Glushich SYU, Lasachko SA, Rykov AA, et al. Review of recent data of etiopathogenesis and methods for diagnosing endometriosis (literature review). Medical and social problems of the family. 2020;25(4):54–68. EDN: IXQCRC</mixed-citation><mixed-citation xml:lang="ru">Глушич С.Ю, Ласачко С.А, Рыков А.А, Железная А.А. Обзор последних данных этиопатогенеза и методов диагностики эндометриоза (обзор литературы) // Медико-социальные проблемы семьи. 2020. Т. 25, № 4. С. 54–68. EDN: IXQCRC</mixed-citation><mixed-citation xml:lang="zh">Glushich SYU, Lasachko SA, Rykov AA, et al. Review of recent data of etiopathogenesis and methods for diagnosing endometriosis (literature review). Medical and social problems of the family. 2020;25(4):54–68. EDN: IXQCRC</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397(10276):839–852. doi: 10.1016/S0140-6736(21)00389-5</mixed-citation><mixed-citation xml:lang="ru">Taylor H.S, Kotlyar A.M, Flores V.A. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations // Lancet. 2021. Vol. 397, N 10276. P. 839–852. doi: 10.1016/S0140-6736(21)00389-5</mixed-citation><mixed-citation xml:lang="zh">Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397(10276):839–852. doi: 10.1016/S0140-6736(21)00389-5</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Orazov MR, Radzinsky VE, Khamoshina MB, et al. Endometriosis-associated infertility: from myths to harsh reality. Difficult Patient. 2019;17(1-2):6–12. EDN: WAJZQN doi: 10.24411/2074-1995-2019-10001</mixed-citation><mixed-citation xml:lang="ru">Оразов М.Р, Радзинский В.Е., Хамошина М.Б., и др. Бесплодие, ассоциированное с эндометриозом: от легенды к суровой реальности // Трудный пациент. 2019. Т. 17, № 1-2. С. 6–12. EDN: WAJZQN doi: 10.24411/2074-1995-2019-10001</mixed-citation><mixed-citation xml:lang="zh">Orazov MR, Radzinsky VE, Khamoshina MB, et al. Endometriosis-associated infertility: from myths to harsh reality. Difficult Patient. 2019;17(1-2):6–12. EDN: WAJZQN doi: 10.24411/2074-1995-2019-10001</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Symons LK, Miller JE, Kay VR, et al. The immunopathophysiology of endometriosis. Trends Mol Med. 2018;24(9):748–762. doi: 10.1016/j.molmed.2018.07.004</mixed-citation><mixed-citation xml:lang="ru">Symons L.K, Miller J.E, Kay V.R., et al. The immunopathophysiology of endometriosis // Trends Mol Med. 2018. Vol. 24, N 9. P. 748–762. doi: 10.1016/j.molmed.2018.07.004</mixed-citation><mixed-citation xml:lang="zh">Symons LK, Miller JE, Kay VR, et al. The immunopathophysiology of endometriosis. Trends Mol Med. 2018;24(9):748–762. doi: 10.1016/j.molmed.2018.07.004</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">de Fáveri C, Fermino PMP, Piovezan AP, Volpato LK. The inflammatory role of pro-resolving mediators in endometriosis: an integrative review // Int J Mol Sci. 2021;22(9):4370. doi: 10.3390/ijms22094370</mixed-citation><mixed-citation xml:lang="ru">de Fáveri C., Fermino P.M.P., Piovezan A.P., Volpato L.K. The inflammatory role of pro-resolving mediators in endometriosis: an integrative review // Int J Mol Sci. 2021. Vol. 22, N 9. P. 4370. doi: 10.3390/ijms22094370</mixed-citation><mixed-citation xml:lang="zh">de Fáveri C, Fermino PMP, Piovezan AP, Volpato LK. The inflammatory role of pro-resolving mediators in endometriosis: an integrative review // Int J Mol Sci. 2021;22(9):4370. doi: 10.3390/ijms22094370</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Ramírez-Pavez TN, Machado-Linde F, García-Peñarrubia P, et al. Optimization of peritoneal fluid and leukocyte collection in patients with endometriosis. Fertil Steril. 2023;120(4):917–919. doi: 10.1016/j.fertnstert.2023.06.030</mixed-citation><mixed-citation xml:lang="ru">Ramírez-Pavez T.N., Machado-Linde F., García-Peñarrubia P., et al. Optimization of peritoneal fluid and leukocyte collection in patients with endometriosis // Fertil Steril. 2023. Vol. 120, N 4. P. 917–919. doi: 10.1016/j.fertnstert.2023.06.030</mixed-citation><mixed-citation xml:lang="zh">Ramírez-Pavez TN, Machado-Linde F, García-Peñarrubia P, et al. Optimization of peritoneal fluid and leukocyte collection in patients with endometriosis. Fertil Steril. 2023;120(4):917–919. doi: 10.1016/j.fertnstert.2023.06.030</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Kudryavtseva EV, Geets AV, Mangileva YaA, et al. Modern non-invasive diagnosis of endometriosis. Ural Medical Journal. 2023;22(4):140–147. EDN: CONKMJ doi: 10.52420/2071-5943-2023-22-4-140-147</mixed-citation><mixed-citation xml:lang="ru">Кудрявцева Е.В., Геец А.В., Мангилева Я.А., и др. Современные неинвазивные методы диагностики эндометриоза // Уральский медицинский журнал. 2023. Т. 22, № 4. С. 140–147. EDN: CONKMJ doi: 10.52420/2071-5943-2023-22-4-140-147</mixed-citation><mixed-citation xml:lang="zh">Kudryavtseva EV, Geets AV, Mangileva YaA, et al. Modern non-invasive diagnosis of endometriosis. Ural Medical Journal. 2023;22(4):140–147. EDN: CONKMJ doi: 10.52420/2071-5943-2023-22-4-140-147</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Agarwal SK, Chapron C, Giudice LC, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354.e1–354.e12. doi: 10.1016/j.ajog.2018.12.039</mixed-citation><mixed-citation xml:lang="ru">Agarwal S.K., Chapron C., Giudice L.C., et al. Clinical diagnosis of endometriosis: a call to action // Am J Obstet Gynecol. 2019. Vol. 220, N 4. P. 354.e1–354.e12. doi: 10.1016/j.ajog.2018.12.039</mixed-citation><mixed-citation xml:lang="zh">Agarwal SK, Chapron C, Giudice LC, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354.e1–354.e12. doi: 10.1016/j.ajog.2018.12.039</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Wang XM, Ma ZY, Song N. Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis. Eur Rev Med Pharmacol Sci. 2018;22(9):2513–2518. doi: 10.26355/eurrev_201805_14899</mixed-citation><mixed-citation xml:lang="ru">Wang X.-M., Ma Z.-Y., Song N. Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis // Eur Rev Med Pharmacol Sci. 2018. Vol. 22, N 9. P. 2513–2518. doi: 10.26355/eurrev_201805_14899</mixed-citation><mixed-citation xml:lang="zh">Wang XM, Ma ZY, Song N. Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis. Eur Rev Med Pharmacol Sci. 2018;22(9):2513–2518. doi: 10.26355/eurrev_201805_14899</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Shields GS, Slavich GM, Perlman G, et al. The short-term reliability and long-term stability of salivary immune markers. Brain Behav Immun. 2019;81:650–654. doi: 10.1016/j.bbi.2019.06.007</mixed-citation><mixed-citation xml:lang="ru">Shields G.S., Slavich G.M., Perlman G., et al. The short-term reliability and long-term stability of salivary immune markers // Brain Behav Immun. 2019. Vol. 81. P. 650–654. doi: 10.1016/j.bbi.2019.06.007</mixed-citation><mixed-citation xml:lang="zh">Shields GS, Slavich GM, Perlman G, et al. The short-term reliability and long-term stability of salivary immune markers. Brain Behav Immun. 2019;81:650–654. doi: 10.1016/j.bbi.2019.06.007</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Monnaka VU, Hernandes C, Heller D, Podgaec S. Overview of miRNAs for the non-invasive diagnosis of endometriosis: evidence, challenges and strategies. A systematic review. Einstein (Sao Paulo). 2021;19:eRW5704. doi: 10.31744/einstein_journal/2021RW5704</mixed-citation><mixed-citation xml:lang="ru">Monnaka V.U., Hernandes C., Heller D., Podgaec S. Overview of miRNAs for the non-invasive diagnosis of endometriosis: evidence, challenges and strategies. A systematic review // Einstein (Sao Paulo). 2021. Vol. 19. P. eRW5704. doi: 10.31744/einstein_journal/2021RW5704</mixed-citation><mixed-citation xml:lang="zh">Monnaka VU, Hernandes C, Heller D, Podgaec S. Overview of miRNAs for the non-invasive diagnosis of endometriosis: evidence, challenges and strategies. A systematic review. Einstein (Sao Paulo). 2021;19:eRW5704. doi: 10.31744/einstein_journal/2021RW5704</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Smolarz B, Szyłło K, Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature). Int J Mol Sci. 2021;22(19):10554. doi: 10.3390/ijms221910554</mixed-citation><mixed-citation xml:lang="ru">Smolarz B., Szyłło K., Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature) // Int J Mol Sci. 2021. Vol. 22, N 19. P. 10554. doi: 10.3390/ijms221910554</mixed-citation><mixed-citation xml:lang="zh">Smolarz B, Szyłło K, Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature). Int J Mol Sci. 2021;22(19):10554. doi: 10.3390/ijms221910554</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Kondera-Anasz Z, Sikora J, Mielczarek-Palacz A, Jońca M. Concentrations of interleukin (IL)-1alpha, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2005;123(2):198–203. doi: 10.1016/j.ejogrb.2005.04.019</mixed-citation><mixed-citation xml:lang="ru">Kondera-Anasz Z., Sikora J., Mielczarek-Palacz A., Jońca M. Concentrations of interleukin (IL)-1alpha, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis // Eur J Obstet Gynecol Reprod Biol. 2005. Vol. 123, N 2. P. 198–203. doi: 10.1016/j.ejogrb.2005.04.019</mixed-citation><mixed-citation xml:lang="zh">Kondera-Anasz Z, Sikora J, Mielczarek-Palacz A, Jońca M. Concentrations of interleukin (IL)-1alpha, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2005;123(2):198–203. doi: 10.1016/j.ejogrb.2005.04.019</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Incognito GG, Di Guardo F, Gulino FA, et al. Interleukin-6 as a useful predictor of endometriosis-associated infertility: a systematic review. Int J Fertil Steril. 2023;17(4):226–230. doi: 10.22074/ijfs.2023.557683.1329</mixed-citation><mixed-citation xml:lang="ru">Incognito G.G., Di Guardo F., Gulino F.A., et al. Interleukin-6 as a useful predictor of endometriosis-associated infertility: a systematic review // Int J Fertil Steril. 2023. Vol. 17, N 4. P. 226–230. doi: 10.22074/ijfs.2023.557683.1329</mixed-citation><mixed-citation xml:lang="zh">Incognito GG, Di Guardo F, Gulino FA, et al. Interleukin-6 as a useful predictor of endometriosis-associated infertility: a systematic review. Int J Fertil Steril. 2023;17(4):226–230. doi: 10.22074/ijfs.2023.557683.1329</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019;40(4):1048–1079. doi: 10.1210/er.2018-00242</mixed-citation><mixed-citation xml:lang="ru">Bulun S.E., Yilmaz B.D., Sison C., et al. Endometriosis // Endocr Rev. 2019. Vol. 40, N 4. P. 1048–79. doi: 10.1210/er.2018-00242</mixed-citation><mixed-citation xml:lang="zh">Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019;40(4):1048–1079. doi: 10.1210/er.2018-00242</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Allaire C, Bedaiwy MA, Yong PJ. Diagnosis and management of endometriosis. CMAJ. 2023;195(10):E363–E371. doi: 10.1503/cmaj.220637</mixed-citation><mixed-citation xml:lang="ru">Allaire C., Bedaiwy M.A., Yong P.J. Diagnosis and management of endometriosis // CMAJ. 2023. Vol. 195, N 10. P. E363–Е371. doi: 10.1503/cmaj.220637</mixed-citation><mixed-citation xml:lang="zh">Allaire C, Bedaiwy MA, Yong PJ. Diagnosis and management of endometriosis. CMAJ. 2023;195(10):E363–E371. doi: 10.1503/cmaj.220637</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022;379:e070750. doi: 10.1136/bmj-2022-070750</mixed-citation><mixed-citation xml:lang="ru">Horne A.W., Missmer S.A. Pathophysiology, diagnosis, and management of endometriosis // BMJ. 2022. Vol. 379. doi: 10.1136/bmj-2022-070750</mixed-citation><mixed-citation xml:lang="zh">Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022;379:e070750. doi: 10.1136/bmj-2022-070750</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Nisenblat V, Bossuyt PM, Shaikh R, et al. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2016(5):CD012179. doi: 10.1002/14651858.CD012179</mixed-citation><mixed-citation xml:lang="ru">Nisenblat V., Bossuyt P.M.M., Shaikh R., et al. Blood biomarkers for the non-invasive diagnosis of endometriosis // Cochrane Database Syst Rev. 2016. Vol. 2016, N 5. P. CD012179. doi: 10.1002/14651858.CD012179</mixed-citation><mixed-citation xml:lang="zh">Nisenblat V, Bossuyt PM, Shaikh R, et al. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2016(5):CD012179. doi: 10.1002/14651858.CD012179</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Nam Y, Kim YY, Chang JY, Kho HS. Salivary biomarkers of inflammation and oxidative stress in healthy adults. Arch Oral Biol. 2019;97:215–222. doi: 10.1016/j.archoralbio.2018.10.026</mixed-citation><mixed-citation xml:lang="ru">Nam Y., Kim Y.-Y., Chang J.-Y., Kho H.-S. Salivary biomarkers of inflammation and oxidative stress in healthy adults // Arch Oral Biol. 2019. Vol. 97. P. 215–22. doi: 10.1016/j.archoralbio.2018.10.026</mixed-citation><mixed-citation xml:lang="zh">Nam Y, Kim YY, Chang JY, Kho HS. Salivary biomarkers of inflammation and oxidative stress in healthy adults. Arch Oral Biol. 2019;97:215–222. doi: 10.1016/j.archoralbio.2018.10.026</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Szabo YZ, Slavish DC. Measuring salivary markers of inflammation in health research: A review of methodological considerations and best practices. Psychoneuroendocrinology. 2021;124:105069. doi: 10.1016/j.psyneuen.2020.105069</mixed-citation><mixed-citation xml:lang="ru">Szabo Y.Z., Slavish D.C. Measuring salivary markers of inflammation in health research: A review of methodological considerations and best practices // Psychoneuroendocrinology. 2021. Vol. 124. doi: 10.1016/j.psyneuen.2020.105069</mixed-citation><mixed-citation xml:lang="zh">Szabo YZ, Slavish DC. Measuring salivary markers of inflammation in health research: A review of methodological considerations and best practices. Psychoneuroendocrinology. 2021;124:105069. doi: 10.1016/j.psyneuen.2020.105069</mixed-citation></citation-alternatives></ref></ref-list></back></article>
